Georgia

A snapshot of PrEP scale-up, registration and resources for Georgia.

  • 200-400
    Estimated Cumulative Number of People Initiating PrEP

    Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.

Data Updated: April 11, 2022

Drug Registration Status

  • Gilead's Truvada (TDF/FTC) registration
    Approved
  • Generic versions of TDF/FTC for prevention
    Approved
  • Viiv’s Apretude (CAB for PrEP) Registration
    Not approved
  • IPM’s Dapivirine Ring Registration
    Not approved

Types of Delivery Projects

  • Demonstration projects, which road-test the use of new options in real-world settings—not in a trial site. They have a formal evaluation component that is designed to address specific elements of introduction such as infrastructure needs and ways individuals can integrate it into daily activities.

Research, Demonstration and Implementation Projects

Policy Framework

Funding

  • The Global Fund

Resources for Georgia